Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Enterprise Value (2016 - 2025)

Fortress Biotech has reported Enterprise Value over the past 13 years, most recently at -$67.1 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$67.1 million for Q4 2025, up 17.85% from a year ago — trailing twelve months through Dec 2025 was -$67.1 million (up 17.85% YoY), and the annual figure for FY2025 was -$67.1 million, up 17.85%.
  • Enterprise Value for Q4 2025 was -$67.1 million at Fortress Biotech, up from -$76.9 million in the prior quarter.
  • Over the last five years, Enterprise Value for FBIO hit a ceiling of -$67.1 million in Q4 2025 and a floor of -$191.8 million in Q1 2022.
  • Median Enterprise Value over the past 5 years was -$111.6 million (2023), compared with a mean of -$125.2 million.
  • Biggest five-year swings in Enterprise Value: plummeted 663.28% in 2021 and later soared 40.05% in 2023.
  • Fortress Biotech's Enterprise Value stood at -$188.5 million in 2021, then rose by 9.85% to -$170.0 million in 2022, then soared by 40.05% to -$101.9 million in 2023, then rose by 19.87% to -$81.6 million in 2024, then grew by 17.85% to -$67.1 million in 2025.
  • The last three reported values for Enterprise Value were -$67.1 million (Q4 2025), -$76.9 million (Q3 2025), and -$80.9 million (Q2 2025) per Business Quant data.